Amending Synthetic Drug Control Act 1 2 3 Summary 4 Amends ineffective law that simply address the problem of synthetic drugs by passing legislation to make 5 specific chemical formulations of synthetic drugs illegal. These specific chemical formulations become 6 dated quickly. This bill goes after broad base formulations that create or mimic the effect of cannabis or 7 certain controlled substances and thereby helps law enforcement to stay ahead of criminal drug activity. 8 Additionally it addresses weakness in the Analog statute that allows clever distributors to cloak products 9 with an innocuous name in order to insulate themselves by marking packages: “Not For Human 10 Consumption.” 11 12 Model Legislation 13 14 Section 1. Short Title. Amending Synthetic Drug Control 15 16 Section 2. Purpose. Adds various synthetic drug compounds including various structural classes of those 17 compounds to the list of Schedule I controlled substances. Deletes from the definition of controlled 18 substance analog the requirement that a substance must be intended for human consumption to be 19 considered an analog of a controlled substance with a chemical structure substantially similar to that of a 20 controlled substance in Schedule I or II, or that was specifically designed to produce an effect substantially 21 similar to that of a controlled substance in Schedule I or II. 22 23 Section 3. Definition. 24 (f) "Controlled Substance" means (i) a drug, substance, or 25 immediate precursor, or synthetic drug in the Schedules of 26 Article II of this Act or (ii) a drug or other substance, or 27 immediate precursor, designated as a controlled substance by 28 29 the Department through administrative rule. The term does not 30 include distilled spirits, wine, malt beverages, or tobacco, as terms are defined or used in… (Reference 31 local state definitions of terms) 32 33 34 35 Section 4. Amending Synthetic Drug Control Act. 36 Sec. 204. 37 (a) The controlled substances listed in this 38 Section are included in Schedule I. 39 (b) Unless specifically excepted or unless listed in 40 another schedule, any of the following opiates, including their 41 isomers, esters, ethers, salts, and salts of isomers, esters, 42 and ethers, whenever the existence of such isomers, esters, 43 ethers and salts is possible within the specific chemical 44 designation: 45 (1) Acetylmethadol; 46 (1.1) Acetyl-alpha-methylfentanyl 47 (N-[1-(1-methyl-2-phenethyl)- 48

4-piperidinyl]-N-phenylacetamide); 49 (2) Allylprodine; 50 (3) Alphacetylmethadol, except 51 levo-alphacetylmethadol (also known as levo-alpha- 52 acetylmethadol, levomethadyl acetate, or LAAM); 53 (4) Alphameprodine; 54 (5) Alphamethadol; 55 (6) Alpha-methylfentanyl 56 (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl) 57 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- 58 propanilido) piperidine; 59 (6.1) Alpha-methylthiofentanyl 60 61 (N-[1-methyl-2-(2-thienyl)ethyl- 62 4-piperidinyl]-N-phenylpropanamide); 63 (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP); 64 (7.1) PEPAP 65 (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); 66 (8) Benzethidine; 67 (9) Betacetylmethadol; 68 (9.1) Beta-hydroxyfentanyl 69 (N-[1-(2-hydroxy-2-phenethyl)- 70 4-piperidinyl]-N-phenylpropanamide); 71 (10) Betameprodine; 72 (11) Betamethadol; 73 (12) Betaprodine; 74 (13) Clonitazene; 75 (14) Dextromoramide; 76 (15) Diampromide; 77 (16) Diethylthiambutene; 78 (17) Difenoxin; 79 (18) Dimenoxadol; 80 (19) Dimepheptanol; 81 (20) Dimethylthiambutene; 82 (21) Dioxaphetylbutyrate; 83 (22) Dipipanone; 84 (23) Ethylmethylthiambutene; 85 (24) Etonitazene; 86 (25) Etoxeridine; 87 88 (26) Furethidine; 89 (27) Hydroxpethidine; 90 (28) Ketobemidone; 91 (29) Levomoramide; 92 (30) Levophenacylmorphan; 93 (31) 3-Methylfentanyl 94 (N-[3-methyl-1-(2-phenylethyl)- 95 4-piperidyl]-N-phenylpropanamide); 96

(31.1) 3-Methylthiofentanyl 97 (N-[(3-methyl-1-(2-thienyl)ethyl- 98 4-piperidinyl]-N-phenylpropanamide); 99 (32) Morpheridine; 100 (33) Noracymethadol; 101 (34) Norlevorphanol; 102 (35) Normethadone; 103 (36) Norpipanone; 104 (36.1) Para-fluorofentanyl 105 (N-(4-fluorophenyl)-N-[1-(2-phenethyl)- 106 4-piperidinyl]propanamide); 107 (37) Phenadoxone; 108 (38) Phenampromide; 109 (39) Phenomorphan; 110 (40) Phenoperidine; 111 (41) Piritramide; 112 (42) Proheptazine; 113 (43) Properidine; 114 115 (44) Propiram; 116 (45) Racemoramide; 117 (45.1) Thiofentanyl 118 (N-phenyl-N-[1-(2-thienyl)ethyl- 119 4-piperidinyl]-propanamide); 120 (46) Tilidine; 121 (47) Trimeperidine; 122 (48) Beta-hydroxy-3-methylfentanyl (other name: 123 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]- 124 N-phenylpropanamide). 125 (c) Unless specifically excepted or unless listed in 126 another schedule, any of the following opium derivatives, its 127 salts, isomers and salts of isomers, whenever the existence of 128 such salts, isomers and salts of isomers is possible within the 129 specific chemical designation: 130 (1) Acetorphine; 131 (2) Acetyldihydrocodeine; 132 (3) Benzylmorphine; 133 (4) Codeine methylbromide; 134 (5) Codeine-N-Oxide; 135 (6) Cyprenorphine; 136 (7) Desomorphine; 137 (8) Diacetyldihydromorphine (Dihydroheroin); 138 (9) Dihydromorphine; 139 (10) Drotebanol; 140 (11) Etorphine (except hydrochloride salt); 141 142 (12) Heroin; 143 (13) Hydromorphinol; 144

(14) Methyldesorphine; 145 (15) Methyldihydromorphine; 146 (16) Morphine methylbromide; 147 (17) Morphine methylsulfonate; 148 (18) Morphine-N-Oxide; 149 (19) Myrophine; 150 (20) Nicocodeine; 151 (21) Nicomorphine; 152 (22) Normorphine; 153 (23) Pholcodine; 154 (24) Thebacon. 155 (d) Unless specifically excepted or unless listed in 156 another schedule, any material, compound, mixture, or 157 preparation which contains any quantity of the following 158 hallucinogenic substances, or which contains any of its salts, 159 isomers and salts of isomers, whenever the existence of such 160 salts, isomers, and salts of isomers is possible within the 161 specific chemical designation (for the purposes of this 162 paragraph only, the term "isomer" includes the optical, 163 position and geometric isomers): 164 (1) 3,4-methylenedioxyamphetamine 165 (alpha-methyl,3,4-methylenedioxyphenethylamine, 166 methylenedioxyamphetamine, MDA); 167 (1.1) Alpha-ethyltryptamine 168 169 (some trade or other names: etryptamine; 170 MONASE; alpha-ethyl-1H-indole-3-ethanamine; 171 3-(2-aminobutyl)indole; a-ET; and AET); 172 (2) 3,4-methylenedioxymethamphetamine (MDMA); 173 (2.1) 3,4-methylenedioxy-N-ethylamphetamine 174 (also known as: N-ethyl-alpha-methyl- 175 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE, 176 and MDEA); 177 (2.2) N-Benzylpiperazine (BZP); 178 (2.2-1) Trifluoromethylphenylpiperazine (TFMPP); 179 (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA); 180 (4) 3,4,5-trimethoxyamphetamine (TMA); 181 (5) (Blank); 182 (6) Diethyltryptamine (DET); 183 (7) Dimethyltryptamine (DMT); 184 (7.1) 5-Methoxy-diallyltryptamine; 185 (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP); 186 (9) Ibogaine (some trade and other names: 187 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy- 188 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] 189 indole; Tabernanthe iboga); 190 (10) Lysergic acid diethylamide; 191 (10.1) Salvinorin A; 192

(10.5) Salvia divinorum (meaning all parts of the plant 193 presently classified botanically as Salvia divinorum, 194 whether growing or not, the seeds thereof, any extract from 195 any part of that plant, and every compound, manufacture, 196 salts, isomers, and salts of isomers whenever the existence 197 of such salts, isomers, and salts of isomers is possible 198 within the specific chemical designation, derivative, 199 mixture, or preparation of that plant, its seeds or 200 extracts); 201 (11) 3,4,5-trimethoxyphenethylamine (Mescaline); 202 (12) Peyote (meaning all parts of the plant presently 203 classified botanically as Lophophora williamsii Lemaire, 204 whether growing or not, the seeds thereof, any extract from 205 any part of that plant, and every compound, manufacture, 206 salts, derivative, mixture, or preparation of that plant, 207 its seeds or extracts); 208 (13) N-ethyl-3-piperidyl benzilate (JB 318); 209 (14) N-methyl-3-piperidyl benzilate; 210 (14.1) N-hydroxy-3,4-methylenedioxyamphetamine 211 (also known as N-hydroxy-alpha-methyl- 212 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA); 213 (15) Parahexyl; some trade or other names: 214 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H- 215 dibenzo (b,d) pyran; Synhexyl; 216 (16) Psilocybin; 217 (17) Psilocyn; 218 (18) Alpha-methyltryptamine (AMT); 219 (19) 2,5-dimethoxyamphetamine 220 (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); 221 222 (20) 4-bromo-2,5-dimethoxyamphetamine 223 (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 224 4-bromo-2,5-DMA); 225 (20.1) 4-Bromo-2,5 dimethoxyphenethylamine. 226 Some trade or other names: 2-(4-bromo- 227 2,5-dimethoxyphenyl)-1-aminoethane; 228 alpha-desmethyl DOB, 2CB, Nexus; 229 (21) 4-methoxyamphetamine 230 (4-methoxy-alpha-methylphenethylamine; 231 paramethoxyamphetamine; PMA); 232 (22) (Blank); 233 (23) Ethylamine analog of phencyclidine. 234 Some trade or other names: 235 N-ethyl-1-phenylcyclohexylamine, 236 (1-phenylcyclohexyl) ethylamine, 237 N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE; 238 (24) Pyrrolidine analog of phencyclidine. Some trade 239 or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy, 240

PHP; 241 (25) 5-methoxy-3,4-methylenedioxy-amphetamine; 242 (26) 2,5-dimethoxy-4-ethylamphetamine 243 (another name: DOET); 244 (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine 245 (another name: TCPy); 246 (28) (Blank); 247 (29) Thiophene analog of phencyclidine (some trade 248 249 or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 250 2-thienyl analog of phencyclidine; TPCP; TCP); 251 (30) Bufotenine (some trade or other names: 252 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole; 253 3-(2-dimethylaminoethyl)-5-indolol; 254 5-hydroxy-N,N-dimethyltryptamine; 255 N,N-dimethylserotonin; mappine); 256 (31) 1-Pentyl-3-(1-naphthoyl)indole 257 Some trade or other names: JWH-018; 258 (32) 1-Butyl-3-(1-naphthoyl)indole 259 Some trade or other names: JWH-073; 260 (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 261 (2-iodophenyl)methanone 262 Some trade or other names: AM-694; 263 (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 264 (2-methyloctan-2-yl)phenol 265 Some trade or other names: CP 47,497 266 and its C6, C8 and C9 homologs; 267 (34.5) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 268 (2-methyloctan-2-yl)phenol), where side chain n=5; 269 and homologues where side chain n=4, 6, or 7; Some 270 trade or other names: CP 47,497; 271 (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- 272 (2-methyloctan-2-yl)-6a,7, 273 10,10a-tetrahydrobenzo[c]chromen-1-ol 274 Some trade or other names: HU-210; 275 276 (35.5) (6aS,10aS)-9-(hydroxymethyl)-6,6- 277 dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 278 tetrahydrobenzo[c]chromen-1-ol, its isomers, 279 salts, and salts of isomers; Some trade or other 280 names: HU-210, Dexanabinol; 281 (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)- 282 6,6-dimethyl-3-(2-methyloctan-2-yl)- 283 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 284 Some trade or other names: HU-211; 285 (37) (2-methyl-1-propyl-1H-indol- 286 3-yl)-1-naphthalenyl-methanone 287 Some trade or other names: JWH-015; 288

(38) 4-methoxynaphthalen-1-yl- 289 (1-pentylindol-3-yl)methanone 290 Some trade or other names: JWH-081; 291 (39) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole 292 Some trade or other names: JWH-122; 293 (40) 2-(2-methylphenyl)-1-(1-pentyl- 294 1H-indol-3-yl)-ethanone 295 Some trade or other names: JWH-251; 296 (41) 1-(2-cyclohexylethyl)-3- 297 (2-methoxyphenylacetyl)indole 298 Some trade or other names: RCS-8, BTW-8 and SR-18; 299 (42) Any compound structurally derived from 300 3-(1-naphthoyl)indole or 1H-indol-3-yl- 301 (1-naphthyl)methane by substitution at the 302 303 nitrogen atom of the indole ring by alkyl, haloalkyl, 304 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, 305 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, 306 or 2-(4-morpholinyl)ethyl whether or not further 307 substituted in the indole ring to any extent, whether 308 or not substituted in the naphthyl ring to any extent. 309 Examples of this structural class include, but are 310 not limited to, JWH-018, AM-2201, JWH-175, JWH-184, 311 and JWH-185; 312 (43) Any compound structurally derived from 313 3-(1-naphthoyl)pyrrole by substitution at the nitrogen 314 atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 315 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl 316 aryl halide, 1-(N-methyl-2-piperidinyl)methyl, 317 or 2-(4-morpholinyl)ethyl, whether or not further 318 substituted in the pyrrole ring to any extent, whether 319 or not substituted in the naphthyl ring to any extent. 320 Examples of this structural class include, but are not 321 limited to, JWH-030, JWH-145, JWH-146, JWH-307, and 322 JWH-368; 323 (44) Any compound structurally derived from 324 1-(1-naphthylmethyl)indene by substitution 325 at the 3-position of the indene ring by alkyl, haloalkyl, 326 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 327 halide, alkyl aryl halide, 1-(N-methyl- 328 2-piperidinyl)methyl, or 2-(4- 329 330 morpholinyl)ethyl whether or not further substituted in 331 the indene ring to any extent, whether or not substituted 332 in the naphthyl ring to any extent. Examples of 333 this structural class include, but are not 334 limited to, JWH-176; 335 (45) Any compound structurally derived from 336

3-phenylacetylindole by substitution at the 337 nitrogen atom of the indole ring with alkyl, haloalkyl, 338 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 339 halide, alkyl aryl halide, 1-(N-methyl-2- 340 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 341 whether or not further substituted in the indole ring 342 to any extent, whether or not substituted in the phenyl 343 ring to any extent. Examples of this structural 344 class include, but are not limited to, JWH-167, 345 JWH-250, JWH-251, and RCS-8; 346 (46) Any compound structurally derived from 347 2-(3-hydroxycyclohexyl)phenol by substitution 348 at the 5-position of the phenolic ring by alkyl, 349 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 350 aryl halide, alkyl aryl halide, 1-(N-methyl-2- 351 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 352 whether or not substituted in the cyclohexyl ring to any 353 extent. Examples of this structural class 354 include, but are not limited to, CP 47, 355 497 and its C8 homologue (cannabicyclohexanol); 356 357 (46.1) Benzoylindoles: Any compound 358 containing a 3-(benzoyl) indole structure with 359 substitution at the nitrogen atom of the 360 indole ring by an alkyl, haloalkyl, alkenyl, 361 cycloalkylmethyl, cycloalkylethyl, 362 1-(N-methyl-2-piperidinyl)methyl, 363 or 2-(4-morpholinyl)ethyl group 364 whether or not further substituted 365 in the indole ring to any extent and 366 whether or not substituted in the phenyl ring 367 to any extent. Examples of this structural class 368 include, but are not limited, to AM-630, 369 AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4; 370 (47) 3,4-Methylenedioxymethcathinone 371 Some trade or other names: Methylone; 372 (48) 3,4-Methyenedioxypyrovalerone 373 Some trade or other names: MDPV; 374 (49) 4-Methylmethcathinone 375 Some trade or other names: Mephedrone; 376 (50) 4-methoxymethcathinone; 377 (51) 4-Fluoromethcathinone; 378 (52) 3-Fluoromethcathinone; 379 (53) 2,5-Dimethoxy-4-(n)-propylthio- 380 phenethylamine; 381 (54) 5-Methoxy-N,N-diisopropyltryptamine; 382 (55) Pentedrone; 383 384

(56) 4-iodo-2,5-dimethoxy-N-((2-methoxy 385 phenyl)methyl)-benzeneethanamine 386 (trade or other name: 25I-NBOMe); 387 (57) 4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl) 388 methyl]-benzeneethanamine (trade or other name: 389 25C-NBOMe); 390 (58) 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl) 391 methyl]-benzeneethanamine (trade or other name: 392 25B-NBOMe); . 393 (59) 3-cyclopropoylindole with 394 substitution at the nitrogen atom of the 395 indole ring by alkyl, haloalkyl, alkenyl, 396 cycloalkylmethyl, cycloalkylethyl, aryl 397 halide, alkyl aryl halide, 398 1-(N-methyl-2-piperidinyl)methyl, or 399 2-(4-morpholinyl)ethyl, whether or not 400 further substituted on the indole ring 401 to any extent, whether or not substituted 402 on the cyclopropyl ring to any extent: 403 including but not limited to XLR11, 404 UR144, FUB-144; 405 (60) 3-adamantoylindole with 406 substitution at the nitrogen atom of the 407 indole ring by alkyl, haloalkyl, alkenyl, 408 cycloalkylmethyl, cycloalkylethyl, 409 aryl halide, alkyl aryl halide, 410 411 1-(N-methyl-2-piperidinyl)methyl, or 412 2-(4-morpholinyl)ethyl, whether or not 413 further substituted on the indole ring to 414 any extent, whether or not substituted on 415 the adamantyl ring to any extent: including 416 but not limited to AB-001; 417 (61) N-(adamantyl)-indole-3-carboxamide 418 with substitution at the nitrogen atom of the 419 indole ring by alkyl, haloalkyl, alkenyl, 420 cycloalkylmethyl, cycloalkylethyl, aryl halide, 421 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, 422 or 2-(4-morpholinyl)ethyl, whether or not further 423 substituted on the indole ring to any extent, whether 424 or not substituted on the adamantyl ring to any 425 extent: including but not limited to 426 APICA/2NE-1, STS-135; 427 (62) N-(adamantyl)-indazole-3-carboxamide 428 with substitution at a nitrogen atom of the indazole 429 ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 430 cycloalkylethyl, aryl halide, alkyl aryl halide, 431 1-(N-methyl-2-piperidinyl)methyl, or 432

2-(4-morpholinyl)ethyl, whether or not further 433 substituted on the indazole ring to any extent, 434 whether or not substituted on the adamantyl 435 ring to any extent: including but not limited 436 to AKB48, 5F-AKB48; 437 438 (63) 1H-indole-3-carboxylic acid 8-quinolinyl 439 ester with substitution at the nitrogen atom of the 440 indole ring by alkyl, haloalkyl, alkenyl, 441 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl 442 aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 443 2-(4-morpholinyl)ethyl, whether or not further 444 substituted on the indole ring to any extent, 445 whether or not substituted on the quinoline ring 446 to any extent: including but not limited to PB22, 447 5F-PB22, FUB-PB-22; 448 (64) 3-(1-naphthoyl)indazole with 449 substitution at the nitrogen atom of the 450 indazole ring by alkyl, haloalkyl, 451 alkenyl, cycloalkylmethyl, cycloalkylethyl, 452 aryl halide, alkyl aryl halide, 453 1-(N-methyl-2-piperidinyl)methyl, or 454 2-(4-morpholinyl)ethyl, whether or not further 455 substituted on the indazole ring to any extent, 456 whether or not substituted on the naphthyl ring 457 to any extent: including but not limited to 458 THJ-018, THJ-2201; 459 (65) 2-(1-naphthoyl)benzimidazole with 460 substitution at the nitrogen atom of the benzimidazole 461 ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 462 cycloalkylethyl, aryl halide, alkyl aryl halide, 463 1-(N-methyl-2-piperidinyl)methyl, or 464 465 2-(4-morpholinyl)ethyl, whether or not further 466 substituted on the benzimidazole ring to any extent, 467 whether or not substituted on the naphthyl ring to 468 any extent: including, but not limited to FUBIMINA; 469 (66) N-(1-amino-3-methyl-1-oxobutan-2-yl) 470 -1H-indazole-3-carboxamide with substitution on the 471 nitrogen atom of the indazole ring by alkyl, 472 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 473 aryl halide, alkyl aryl halide, 1-(N-methyl-2- 474 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 475 whether or not further substituted on the indazole 476 ring to any extent: including but not limited to 477 AB-PINACA, AB-FUBINACA, AB-CHMINACA; 478 (67) N-(1-amino-3,3-dimethyl-1-oxobutan- 479 2-yl)-1H-indazole-3-carboxamide with substitution 480

on the nitrogen atom of the indazole ring by alkyl, 481 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 482 aryl halide, alkyl aryl halide, 1-(N-methyl-2- 483 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether 484 or not further substituted on the indazole ring to any 485 extent: including but not limited to ADB-PINACA, 486 ADB-FUBINACA; 487 (68) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)- 488 1H-indole-3-carboxamide with substitution on the nitrogen 489 atom of the indole ring by alkyl, haloalkyl, alkenyl, 490 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl 491 492 aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 493 2-(4-morpholinyl)ethyl, whether or not further 494 substituted on the indole ring to any extent: 495 including but not limited to ADBICA, 5F-ADBICA; 496 (69) N-(1-amino-3-methyl-1-oxobutan-2-yl)- 497 1H-indole-3-carboxamide with substitution on the 498 nitrogen atom of the indole ring by alkyl, haloalkyl, 499 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 500 halide, alkyl aryl halide, 1-(N-methyl-2- 501 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 502 whether or not further substituted on the indole 503 ring to any extent: including but not limited 504 to ABICA, 5F-ABICA; 505 (70) Methyl 2-(1H-indazole-3-carboxamido)- 506 3-methylbutanoate with substitution on the nitrogen 507 atom of the indazole ring by alkyl, haloalkyl, 508 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 509 halide, alkyl aryl halide, 1-(N-methyl-2- 510 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 511 whether or not further substituted on the indazole 512 ring to any extent: including but not limited to AMB, 513 5F-AMB. 514 (e) Unless specifically excepted or unless listed in 515 another schedule, any material, compound, mixture, or 516 preparation which contains any quantity of the following 517 substances having a depressant effect on the central nervous 518 519 system, including its salts, isomers, and salts of isomers 520 whenever the existence of such salts, isomers, and salts of 521 isomers is possible within the specific chemical designation: 522 (1) mecloqualone; 523 (2) methaqualone; and 524 (3) gamma hydroxybutyric acid. 525 (f) Unless specifically excepted or unless listed in 526 another schedule, any material, compound, mixture, or 527 preparation which contains any quantity of the following 528

substances having a stimulant effect on the central nervous 529 system, including its salts, isomers, and salts of isomers: 530 (1) Fenethylline; 531 (2) N-ethylamphetamine; 532 (3) Aminorex (some other names: 533 2-amino-5-phenyl-2-oxazoline; aminoxaphen; 534 4-5-dihydro-5-phenyl-2-oxazolamine) and its 535 salts, optical isomers, and salts of optical isomers; 536 (4) Methcathinone (some other names: 537 2-methylamino-1-phenylpropan-1-one; 538 Ephedrone; 2-(methylamino)-propiophenone; 539 alpha-(methylamino)propiophenone; N-methylcathinone; 540 methycathinone; Monomethylpropion; UR 1431) and its 541 salts, optical isomers, and salts of optical isomers; 542 (5) Cathinone (some trade or other names: 543 2-aminopropiophenone; alpha-aminopropiophenone; 544 2-amino-1-phenyl-propanone; norephedrone); 545 546 (6) N,N-dimethylamphetamine (also known as: 547 N,N-alpha-trimethyl-benzeneethanamine; 548 N,N-alpha-trimethylphenethylamine); 549 (7) (+ or -) cis-4-methylaminorex ((+ or -) cis- 550 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine); 551 (8) 3,4-Methylenedioxypyrovalerone (MDPV). 552 (g) Temporary listing of substances subject to emergency 553 scheduling. Any material, compound, mixture, or preparation 554 that contains any quantity of the following substances: 555 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide 556 (benzylfentanyl), its optical isomers, isomers, salts, 557 and salts of isomers; 558 (2) N-[1(2-thienyl) 559 methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), 560 its optical isomers, salts, and salts of isomers. 561 (h) Synthetic cathinones. Unless specifically excepted, 562 any chemical compound not including bupropion, structurally 563 derived from 2-aminopropan-1-one by substitution at the 564 1-position with either phenyl, naphthyl, or thiophene ring 565 systems, whether or not the compound is further modified in one 566 or more of the following ways: 567 (1) by substitution in the ring system to 568 any extent with alkyl, alkylenedioxy, alkoxy, 569 haloalkyl, hydroxyl, or halide substituents, whether 570 or not further substituted in the ring system 571 by one or more other univalent substituents. 572 573 Examples of this class include, but are not 574 limited to, 3,4-Methylenedioxycathinone 575 (bk-MDA); 576

(2) by substitution at the 3-position 577 with an acyclic alkyl substituent. Examples of 578 this class include, but are not limited to, 579 2-methylamino-1-phenylbutan-1-one 580 (buphedrone); or 581 (3) by substitution at the 2-amino nitrogen 582 atom with alkyl, dialkyl, benzyl, or methoxybenzyl 583 groups, or by inclusion of the 2-amino nitrogen atom 584 in a cyclic structure. Examples of this class include, 585 but are not limited to, Dimethylcathinone, Ethcathinone, 586 and a-Pyrrolidinopropiophenone (a-PPP). 587 (Source: P.A. 97-192, eff. 7-22-11; 97-193, eff. 1-1-12; 588 97-194, eff. 7-22-11; 97-334, eff. 1-1-12; 97-813, eff. 589 7-13-12; 97-872, eff. 7-31-12; 98-987, eff. 1-1-15.) 590 591 Sec (Regarding Manufacture or Delivery of Controlled Synthetic drugs). 401. 592 Except as authorized by this Act, it is unlawful 593 for any person knowingly to manufacture or deliver, or possess 594 with intent to manufacture or deliver, a controlled substance 595 other than methamphetamine, a counterfeit substance, or a 596 controlled substance analog. A violation of this Act with 597 respect to each of the controlled substances listed herein 598 constitutes a single and separate violation of this Act. For 599 purposes of this Section, "controlled substance analog" or 600 "analog" means a substance which is intended for human 601 consumption, other than a controlled substance, that has a 602 chemical structure substantially similar to that of a 603 controlled substance in Schedule I or II, or that was 604 specifically designed to produce an effect substantially 605 similar to that of a controlled substance in Schedule I or II. 606 Examples of chemical classes in which controlled substance 607 analogs are found include, but are not limited to, the 608 following: phenethylamines, N-substituted piperidines, 609 morphinans, ecgonines, quinazolinones, substituted indoles, 610 and arylcycloalkylamines. For purposes of this Act, a 611 controlled substance analog shall be treated in the same manner 612 as the controlled substance to which it is substantially 613 similar. 614 615 Sec. 402 (Regarding Possession of Controlled Synthetic Drugs). 616 Except as otherwise authorized by this Act, it is 617 unlawful for any person knowingly to possess a controlled or 618 counterfeit substance or controlled substance analog. A 619 violation of this Act with respect to each of the controlled 620 substances listed herein constitutes a single and separate 621 violation of this Act. For purposes of this Section, 622 "controlled substance analog" or "analog" means a substance 623 which is intended for human consumption, other than a 624

controlled substance, that has a chemical structure 625 substantially similar to that of a controlled substance in 626 Schedule I or II, or that was specifically designed to produce 627 628 an effect substantially similar to that of a controlled 629 substance in Schedule I or II. Examples of chemical classes in 630 which controlled substance analogs are found include, but are 631 not limited to, the following: phenethylamines, N-substituted 632 piperidines, morphinans, ecgonines, quinazolinones, 633 substituted indoles, and arylcycloalkylamines. For purposes of 634 this Act, a controlled substance analog shall be treated in the 635 same manner as the controlled substance to which it is 636 substantially similar. 637 638 Section 5. Severability clause. 639 640 Section 6. Repealer clause. 641 642 Section 7. {Insert Effective Date} 643